HUE050913T2 - Kezelési eljárás a szem állapotának javítására nyújtott leadású gyógyszer implantátummal - Google Patents

Kezelési eljárás a szem állapotának javítására nyújtott leadású gyógyszer implantátummal

Info

Publication number
HUE050913T2
HUE050913T2 HUE14805768A HUE14805768A HUE050913T2 HU E050913 T2 HUE050913 T2 HU E050913T2 HU E14805768 A HUE14805768 A HU E14805768A HU E14805768 A HUE14805768 A HU E14805768A HU E050913 T2 HUE050913 T2 HU E050913T2
Authority
HU
Hungary
Prior art keywords
treatment
methods
drug delivery
sustained drug
ocular conditions
Prior art date
Application number
HUE14805768A
Other languages
English (en)
Inventor
Jane-Guo Shiah
Rahul Bhagat
Wendy M Blanda
Thierry Nivaggioli
Lin Peng
Original Assignee
Allergan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=52001114&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HUE050913(T2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Allergan Inc filed Critical Allergan Inc
Publication of HUE050913T2 publication Critical patent/HUE050913T2/hu

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/2031Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A61K9/204Polyesters, e.g. poly(lactide-co-glycolide)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears
    • A61K9/0051Ocular inserts, ocular implants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
HUE14805768A 2013-11-15 2014-11-14 Kezelési eljárás a szem állapotának javítására nyújtott leadású gyógyszer implantátummal HUE050913T2 (hu)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201361904887P 2013-11-15 2013-11-15

Publications (1)

Publication Number Publication Date
HUE050913T2 true HUE050913T2 (hu) 2021-01-28

Family

ID=52001114

Family Applications (1)

Application Number Title Priority Date Filing Date
HUE14805768A HUE050913T2 (hu) 2013-11-15 2014-11-14 Kezelési eljárás a szem állapotának javítására nyújtott leadású gyógyszer implantátummal

Country Status (24)

Country Link
US (1) US20150140062A1 (hu)
EP (2) EP3714875A1 (hu)
JP (2) JP6675307B2 (hu)
KR (3) KR20240058976A (hu)
CN (1) CN105764517A (hu)
AU (3) AU2014348369B2 (hu)
CA (1) CA2929689A1 (hu)
CL (1) CL2016001167A1 (hu)
CY (1) CY1123344T1 (hu)
DK (1) DK3068403T3 (hu)
ES (1) ES2819215T3 (hu)
HU (1) HUE050913T2 (hu)
IL (2) IL245548A0 (hu)
MX (2) MX2016006334A (hu)
MY (1) MY176039A (hu)
NZ (1) NZ719953A (hu)
PH (1) PH12016500869B1 (hu)
PL (1) PL3068403T3 (hu)
PT (1) PT3068403T (hu)
RU (1) RU2690841C1 (hu)
SG (1) SG10201809363SA (hu)
SI (1) SI3068403T1 (hu)
UA (1) UA122117C2 (hu)
WO (1) WO2015073895A1 (hu)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115337254A (zh) * 2015-07-23 2022-11-15 爱瑞制药公司 用于治疗眼病的玻璃体内药物递送系统
CA3087238A1 (en) 2018-05-24 2019-11-28 Celanese EVA Performance Polymers Corporation Implantable device for sustained release of a macromolecular drug compound
AU2019275409A1 (en) 2018-05-24 2020-07-16 Celanese Eva Performance Polymers Llc Implantable device for sustained release of a macromolecular drug compound

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6726918B1 (en) 2000-07-05 2004-04-27 Oculex Pharmaceuticals, Inc. Methods for treating inflammation-mediated conditions of the eye
ES2250504T3 (es) 2000-11-29 2006-04-16 Allergan Inc. Prevencion del rechazo de injerto en el ojo.
US20050048099A1 (en) * 2003-01-09 2005-03-03 Allergan, Inc. Ocular implant made by a double extrusion process
US8119154B2 (en) 2004-04-30 2012-02-21 Allergan, Inc. Sustained release intraocular implants and related methods
US8685435B2 (en) * 2004-04-30 2014-04-01 Allergan, Inc. Extended release biodegradable ocular implants
US20050244500A1 (en) * 2004-04-30 2005-11-03 Allergan, Inc. Intravitreal implants in conjuction with photodynamic therapy to improve vision
US20050244469A1 (en) * 2004-04-30 2005-11-03 Allergan, Inc. Extended therapeutic effect ocular implant treatments
US20090082321A1 (en) * 2007-09-21 2009-03-26 Allergan, Inc. Steroid containing drug delivery systems
US20120207682A1 (en) * 2011-02-11 2012-08-16 Psivida Us, Inc. Methods of treating macular edema using antiedema therapeutics

Also Published As

Publication number Publication date
US20150140062A1 (en) 2015-05-21
KR20220082934A (ko) 2022-06-17
KR20240058976A (ko) 2024-05-07
JP2016538292A (ja) 2016-12-08
AU2020204362A1 (en) 2020-07-23
EP3714875A1 (en) 2020-09-30
PH12016500869A1 (en) 2016-07-04
AU2014348369B2 (en) 2020-04-02
MX2022002306A (es) 2022-03-25
CY1123344T1 (el) 2021-12-31
SI3068403T1 (sl) 2020-11-30
PT3068403T (pt) 2020-09-18
PL3068403T3 (pl) 2021-01-11
CN105764517A (zh) 2016-07-13
AU2014348369A1 (en) 2016-06-09
NZ719953A (en) 2022-01-28
JP6675307B2 (ja) 2020-04-01
JP2020055862A (ja) 2020-04-09
AU2022204607A1 (en) 2022-07-21
WO2015073895A1 (en) 2015-05-21
KR20160085847A (ko) 2016-07-18
EP3068403A1 (en) 2016-09-21
ES2819215T3 (es) 2021-04-15
JP7022735B2 (ja) 2022-02-18
IL290837A (en) 2022-04-01
UA122117C2 (uk) 2020-09-25
EP3068403B1 (en) 2020-06-17
SG10201809363SA (en) 2018-11-29
CL2016001167A1 (es) 2017-01-06
RU2690841C1 (ru) 2019-06-06
MX2016006334A (es) 2016-09-06
PH12016500869B1 (en) 2016-07-04
RU2016119132A (ru) 2017-12-20
CA2929689A1 (en) 2015-05-21
KR102475746B1 (ko) 2022-12-08
DK3068403T3 (da) 2020-09-07
MY176039A (en) 2020-07-22
IL245548A0 (en) 2016-06-30

Similar Documents

Publication Publication Date Title
HK1259482A1 (zh) 具有受控的藥物輸送的植入物
HK1218850A1 (zh) 持續藥物遞送植入物
IL244259A0 (en) Insertion of medical devices
HK1219888A1 (zh) 用於無創眼部藥物遞送的包含聚合物微粒的溫敏性水凝膠
HK1205928A1 (en) Ocular drug delivery system
HK1222116A1 (zh) 用於治療青光眼的能夠植入患者的眼睛內的改善的排液閥
HK1201483A1 (en) Devices for targeted delivery of therapeutic implants
HK1213503A1 (zh) 藥物遞送醫療裝置
EP2833849A4 (en) INTRAOCULAR DELIVERY DEVICES AND ASSOCIATED METHODS
EP2763625A4 (en) INSTALLING OCULAR IMPLANTS IN THE EYE
PT2648663E (pt) Dispositivo para administração por iontoforese de riboflavina na córnea para o tratamento de queratocone
EP2768430A4 (en) CORNEAL IMPLANT STORAGE AND INSTALLATION DEVICES
SG11201502274XA (en) A device for a medical treatment of a sclera
IL290837A (en) Methods for the treatment of ocular diseases using a continuous drug delivery implant
EP4005604C0 (en) ADMINISTRATION OF MEDICINES
EP3071280A4 (en) TREATMENT CATHETER COMPRISING THE ADMINISTRATION OF THERAPEUTIC ENERGY
EP2893903A4 (en) IMPLANTABLE DEVICE FOR MOLDING THE CORD BEND
IL262062A (en) Implantable ophthalmic drug delivery devices
HK1220926A1 (zh) 包含具有增強的降解速率的生物可降解的合金的可植入的醫療裝置
PL2808053T3 (pl) Biokompatybilna elektroda wszczepialna
EP2846747A4 (en) LIGHT ABBAUBARIC AGGREGATE FREEZING SYSTEM FOR EYE TREATMENT
GB201316738D0 (en) Implantable Medical Devices
EP2870971A4 (en) MEDICAMENT FOR THE PREVENTION / TREATMENT OF AN OCULAR DISEASE
HK1223834A1 (zh) 具有生物學活性的胰島素衍生物
EP3041524A4 (en) Intraocular drug delivery and filter device and methods of using same